← Eichor
Study identifier: NCT07711743 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Histological Assessment of Tissue Penetration Depth of Argon Beam Coagulation in Ovarian Endometriomas

Condition: Ovarian Endometrioma · Endometriosis  ·  Sponsor: Insel Gruppe AG, University Hospital Bern

PhaseNA
Planned participants50
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate the depth of tissue penetration of Argon Beam Coagulation (ABC) during laparoscopic surgery for ovarian endometriomas. Researchers want to determine how deeply ABC affects ovarian tissue and to generate data on the safety of this surgical technique. Participants will undergo standard laparoscopic surgery for ovarian endometriomas. During the planned surgical procedure, Argon Beam Coagulation will be applied to the ovarian surface according to the study protocol. The treated tissue will subsequently be excised as part of the planned surgery and analyzed histologically to measure the depth of tissue penetration.

This description comes directly from the study's public registry record.

Talk to the study team

Michael David Mueller, Prof.  ·  +41 31 63 2 12 01  ·  Michel.Mueller@insel.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital of Obstetrics and Gynecology, Inselspital BernBern, Canton of Bern, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07711743